Publicaciones en colaboración con investigadores/as de Johns Hopkins University School of Medicine (25)

2024

  1. Correction to: Analysis of muscle magnetic resonance imaging of a large cohort of patient with VCP-mediated disease reveals characteristic features useful for diagnosis (Journal of Neurology, (2023), 270, 12, (5849-5865), 10.1007/s00415-023-11862-4)

    Journal of Neurology

  2. Event-free survival of maralixibat-treated patients with Alagille syndrome compared to a real-world cohort from GALA

    Hepatology (Baltimore, Md.), Vol. 79, Núm. 6, pp. 1279-1292

  3. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

    Journal of Extracellular Vesicles, Vol. 13, Núm. 2

2023

  1. Analysis of muscle magnetic resonance imaging of a large cohort of patient with VCP-mediated disease reveals characteristic features useful for diagnosis

    Journal of Neurology, Vol. 270, Núm. 12, pp. 5849-5865

  2. Natural history of liver disease in a large international cohort of children with Alagille syndrome: Results from the GALA study

    Hepatology, Vol. 77, Núm. 2, pp. 512-529

2022

  1. Genotype-phenotype correlations in valosin-containing protein disease: a retrospective muticentre study

    Journal of Neurology, Neurosurgery and Psychiatry, Vol. 93, Núm. 10, pp. 1099-1111

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  2. Impact of subspecialty training on management of laryngopharyngeal reflux: results of a worldwide survey

    European Archives of Oto-Rhino-Laryngology, Vol. 278, Núm. 6, pp. 1933-1943

  3. Management of Laryngopharyngeal Reflux Around the World: An International Study

    Laryngoscope, Vol. 131, Núm. 5, pp. E1589-E1597

2020

  1. Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study

    The Lancet Neurology, Vol. 19, Núm. 2, pp. 145-156

  2. Clinical indications for image guided interventional procedures in the musculoskeletal system: a Delphi-based consensus paper from the European Society of Musculoskeletal Radiology (ESSR)—part III, nerves of the upper limb

    European Radiology, Vol. 30, Núm. 3, pp. 1498-1506

  3. Clinical indications for image-guided interventional procedures in the musculoskeletal system: a Delphi-based consensus paper from the European Society of Musculoskeletal Radiology (ESSR)—Part II, elbow and wrist

    European Radiology, Vol. 30, Núm. 4, pp. 2220-2230

  4. Clinical indications for image-guided interventional procedures in the musculoskeletal system: a Delphi-based consensus paper from the European Society of Musculoskeletal Radiology (ESSR)—part I, shoulder

    European Radiology, Vol. 30, Núm. 2, pp. 903-913

  5. Mendelian randomization analysis of n-6 polyunsaturated fatty acid levels and pancreatic cancer risk

    Cancer Epidemiology Biomarkers and Prevention, Vol. 29, Núm. 12, pp. 2735-2739

  6. Neuronal pentraxin 2: A synapse-derived CSF biomarker in genetic frontotemporal dementia

    Journal of Neurology, Neurosurgery and Psychiatry, Vol. 91, Núm. 6, pp. 612-621

  7. The risk of ovarian cancer increases with an increase in the lifetime number of ovulatory cycles: An analysis from the Ovarian Cancer Cohort Consortium (OC3)

    Cancer Research, Vol. 80, Núm. 5, pp. 1210-1218

  8. Whitepaper: Defining and investigating cognitive reserve, brain reserve, and brain maintenance

    Alzheimer's and Dementia, Vol. 16, Núm. 9, pp. 1305-1311

2019

  1. Mechanisms underlying resilience in ageing

    Nature Reviews Neuroscience

  2. Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1

    Antiviral Research, Vol. 170

2015

  1. Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects

    Brain, Vol. 138, Núm. 9, pp. 2701-2715